Janelle C. Arthur, Ph.D. - Publications

Affiliations: 
2009 Microbiology & Immunology University of North Carolina, Chapel Hill, Chapel Hill, NC 
Area:
Neuroinflammation

38 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Wang M, Rousseau B, Qiu K, Huang G, Zhang Y, Su H, Le Bihan-Benjamin C, Khati I, Artz O, Foote MB, Cheng YY, Lee KH, Miao MZ, Sun Y, Bousquet PJ, ... ... Arthur JC, et al. Killing tumor-associated bacteria with a liposomal antibiotic generates neoantigens that induce anti-tumor immune responses. Nature Biotechnology. PMID 37749267 DOI: 10.1038/s41587-023-01957-8  0.435
2022 Hoffner O'Connor M, Berglind A, Kennedy Ng MM, Keith BP, Lynch ZJ, Schaner MR, Steinbach EC, Herzog J, Trad OK, Jeck WR, Arthur JC, Simon JM, Sartor RB, Furey TS, Sheikh SZ. BET Protein Inhibition Regulates Macrophage Chromatin Accessibility and Microbiota-Dependent Colitis. Frontiers in Immunology. 13: 856966. PMID 35401533 DOI: 10.3389/fimmu.2022.856966  0.328
2021 Goc J, Lv M, Bessman NJ, Flamar AL, Sahota S, Suzuki H, Teng F, Putzel GG, Eberl G, Withers DR, Arthur JC, Shah MA, Sonnenberg GF. Dysregulation of ILC3s unleashes progression and immunotherapy resistance in colon cancer. Cell. PMID 34407392 DOI: 10.1016/j.cell.2021.07.029  0.334
2020 Arthur JC. Microbiota and colorectal cancer: colibactin makes its mark. Nature Reviews. Gastroenterology & Hepatology. PMID 32317778 DOI: 10.1038/S41575-020-0303-Y  0.327
2020 Bleich R, Barlogio C, Franks A, Zarmer S, Broberg C, Bulik-Sullivan E, Dogan B, Simpson K, Carroll I, Gharaibeh R, Arthur J. Human Intestinal AIEC Strains Alter the Mucosal Microbiome and Establish a Niche for AIEC and Non‐AIEC Strains in Il10 − / − Mice The Faseb Journal. 34: 1-1. DOI: 10.1096/Fasebj.2020.34.S1.02969  0.312
2019 Ellermann M, Gharaibeh RZ, Fulbright L, Dogan B, Moore LN, Broberg CA, Lopez LR, Rothemich AM, Herzog JW, Rogala A, Gordon IO, Rieder F, Brouwer CR, Simpson KW, Jobin C, ... ... Arthur JC, et al. Yersiniabactin producing AIEC promote inflammation-associated fibrosis in gnotobiotic mice. Infection and Immunity. PMID 31481410 DOI: 10.1128/Iai.00587-19  0.394
2019 Tibbs TN, Lopez LR, Arthur JC. The influence of the microbiota on immune development, chronic inflammation, and cancer in the context of aging. Microbial Cell (Graz, Austria). 6: 324-334. PMID 31403049 DOI: 10.15698/Mic2019.08.685  0.384
2019 Rothemich A, Arthur JC. The Azoxymethane/Il10 Model of Colitis-Associated Cancer (CAC). Methods in Molecular Biology (Clifton, N.J.). 1960: 215-225. PMID 30798535 DOI: 10.1007/978-1-4939-9167-9_19  0.422
2019 Lopez LR, Moore L, Broberg CA, Tibbs TN, Rothemich A, Arthur JC. Tu1856 – The Siderophore Yersiniabactin Potentiates Inflammatory Bowel Disease (IBD)-Associated Fibrosis Gastroenterology. 156: S-1149. DOI: 10.1016/S0016-5085(19)39842-7  0.308
2019 Tibbs TN, Broberg CA, Lopez LR, Rothemich A, Arthur JC. Tu1848 – Escherichia Coli Siderophore Production Induces Intestinal Fibrosis in Il10/ Mice Gastroenterology. 156: S-1146-S-1147. DOI: 10.1016/S0016-5085(19)39834-8  0.373
2016 Monteagudo-Mera A, Arthur JC, Jobin C, Keku T, Bruno-Barcena JM, Azcarate-Peril MA. High purity galacto-oligosaccharides enhance specific Bifidobacterium species and their metabolic activity in the mouse gut microbiome. Beneficial Microbes. 7: 247-64. PMID 26839072 DOI: 10.3920/Bm2015.0114  0.358
2014 Arthur JC, Gharaibeh RZ, Mühlbauer M, Perez-Chanona E, Uronis JM, McCafferty J, Fodor AA, Jobin C. Microbial genomic analysis reveals the essential role of inflammation in bacteria-induced colorectal cancer. Nature Communications. 5: 4724. PMID 25182170 DOI: 10.1038/Ncomms5724  0.435
2013 Baker K, Rath T, Flak MB, Arthur JC, Chen Z, Glickman JN, Zlobec I, Karamitopoulou E, Stachler MD, Odze RD, Lencer WI, Jobin C, Blumberg RS. Neonatal Fc receptor expression in dendritic cells mediates protective immunity against colorectal cancer. Immunity. 39: 1095-107. PMID 24290911 DOI: 10.1016/J.Immuni.2013.11.003  0.44
2013 Arthur JC, Gharaibeh RZ, Uronis JM, Perez-Chanona E, Sha W, Tomkovich S, Mühlbauer M, Fodor AA, Jobin C. VSL#3 probiotic modifies mucosal microbial composition but does not reduce colitis-associated colorectal cancer. Scientific Reports. 3: 2868. PMID 24100376 DOI: 10.1038/Srep02868  0.354
2013 Allen IC, McElvania-TeKippe E, Wilson JE, Lich JD, Arthur JC, Sullivan JT, Braunstein M, Ting JP. Characterization of NLRP12 during the in vivo host immune response to Klebsiella pneumoniae and Mycobacterium tuberculosis. Plos One. 8: e60842. PMID 23577168 DOI: 10.1371/Journal.Pone.0060842  0.597
2013 Arthur JC, Jobin C. The complex interplay between inflammation, the microbiota and colorectal cancer. Gut Microbes. 4: 253-8. PMID 23549517 DOI: 10.4161/Gmic.24220  0.333
2013 Muehlbauer M, Gharaibeh R, Arthur JC, Fodor A, Jobin C. 825 Intestinal Inflammation Targets E. Coli NC101 Transcriptome Response and Promotes Development of Colorectal Cancer (CRC) Gastroenterology. 144: S-144-S-145. DOI: 10.1016/S0016-5085(13)60520-X  0.321
2012 Chen L, Chen Z, Baker K, Halvorsen EM, da Cunha AP, Flak MB, Gerber G, Huang YH, Hosomi S, Arthur JC, Dery KJ, Nagaishi T, Beauchemin N, Holmes KV, Ho JW, et al. The short isoform of the CEACAM1 receptor in intestinal T cells regulates mucosal immunity and homeostasis via Tfh cell induction. Immunity. 37: 930-46. PMID 23123061 DOI: 10.1016/J.Immuni.2012.07.016  0.376
2012 Holl EK, Roney KE, Allen IC, Steinbach E, Arthur JC, Buntzman A, Plevy S, Frelinger J, Ting JP. Plexin-B2 and Plexin-D1 in dendritic cells: expression and IL-12/IL-23p40 production. Plos One. 7: e43333. PMID 22916243 DOI: 10.1371/Journal.Pone.0043333  0.628
2012 Arthur JC, Perez-Chanona E, Mühlbauer M, Tomkovich S, Uronis JM, Fan TJ, Campbell BJ, Abujamel T, Dogan B, Rogers AB, Rhodes JM, Stintzi A, Simpson KW, Hansen JJ, Keku TO, et al. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science (New York, N.Y.). 338: 120-3. PMID 22903521 DOI: 10.1126/Science.1224820  0.448
2012 Allen IC, Wilson JE, Schneider M, Lich JD, Roberts RA, Arthur JC, Woodford RM, Davis BK, Uronis JM, Herfarth HH, Jobin C, Rogers AB, Ting JP. NLRP12 suppresses colon inflammation and tumorigenesis through the negative regulation of noncanonical NF-κB signaling. Immunity. 36: 742-54. PMID 22503542 DOI: 10.1016/J.Immuni.2012.03.012  0.651
2012 Gulati AS, Shanahan MT, Arthur JC, Grossniklaus E, von Furstenberg RJ, Kreuk L, Henning SJ, Jobin C, Sartor RB. Mouse background strain profoundly influences Paneth cell function and intestinal microbial composition. Plos One. 7: e32403. PMID 22384242 DOI: 10.1371/Journal.Pone.0032403  0.327
2012 Bassaganya-Riera J, Viladomiu M, Pedragosa M, De Simone C, Carbo A, Shaykhutdinov R, Jobin C, Arthur JC, Corl BA, Vogel H, Storr M, Hontecillas R. Probiotic bacteria produce conjugated linoleic acid locally in the gut that targets macrophage PPAR γ to suppress colitis. Plos One. 7: e31238. PMID 22363592 DOI: 10.1371/Journal.Pone.0031238  0.42
2012 Allen IC, Lich JD, Arthur JC, Jania CM, Roberts RA, Callaway JB, Tilley SL, Ting JP. Characterization of NLRP12 during the development of allergic airway disease in mice. Plos One. 7: e30612. PMID 22291998 DOI: 10.1371/Journal.Pone.0030612  0.58
2012 Arthur JC, Tomkovich SE, Muehlbauer M, Fan T, Dogan B, Perez-Chanona E, Campbell BJ, Rhodes JM, Simpson KW, Hansen JJ, Jobin C. Mo1603 The E. coli Genotoxic Island Pks Promotes Colorectal Cancer (CRC) Without Impacting Intestinal Inflammation Gastroenterology. 142. DOI: 10.1016/S0016-5085(12)62458-5  0.31
2011 Appleyard CB, Cruz ML, Isidro AA, Arthur JC, Jobin C, De Simone C. Pretreatment with the probiotic VSL#3 delays transition from inflammation to dysplasia in a rat model of colitis-associated cancer. American Journal of Physiology. Gastrointestinal and Liver Physiology. 301: G1004-13. PMID 21903764 DOI: 10.1152/Ajpgi.00167.2011  0.349
2011 Arthur JC, Jobin C. The struggle within: microbial influences on colorectal cancer. Inflammatory Bowel Diseases. 17: 396-409. PMID 20848537 DOI: 10.1002/Ibd.21354  0.379
2011 Uronis JM, Arthur JC, Keku T, Fodor A, Carroll IM, Cruz ML, Appleyard CB, Jobin C. Gut microbial diversity is reduced by the probiotic VSL#3 and correlates with decreased TNBS-induced colitis. Inflammatory Bowel Diseases. 17: 289-97. PMID 20564535 DOI: 10.1002/Ibd.21366  0.354
2011 Arthur JC, Uronis JM, Perez Chanona E, Keku TO, Muehlbauer M, Tomkovich SE, Fan T, Hansen JJ, Jobin C. Inflammation Impacts the Development of Colorectal Cancer Through Changes in Microbial Composition and Associated Genotoxic Capacity Gastroenterology. 140: S-181. DOI: 10.1016/S0016-5085(11)60731-2  0.327
2011 Gulati AS, Shanahan MT, Arthur JC, Grossniklaus E, Jobin C, Sartor RB. Reciprocal Colonization Studies of Germ-Free Mice Demonstrate That Colitis-Susceptible 129/SvEv Mice Have Distinct Patterns of α-Defensin Expression and Downstream Microbial Alterations Relative to Colitis-Resistant C57BL/6 Mice Gastroenterology. 140: S-141. DOI: 10.1016/S0016-5085(11)60572-6  0.32
2011 Whitehead KJ, Schmitz JM, Carroll IM, Arthur JC, Jobin C, Sartor RB. Ingestion of Dietary Carbohydrates Influences the Aggressiveness of Colitis and Intestinal Microbial Composition in IL-10-/- Mice Gastroenterology. 140: S-47. DOI: 10.1016/S0016-5085(11)60187-X  0.422
2010 Arthur JC, Lich JD, Ye Z, Allen IC, Gris D, Wilson JE, Schneider M, Roney KE, O'Connor BP, Moore CB, Morrison A, Sutterwala FS, Bertin J, Koller BH, Liu Z, et al. Cutting edge: NLRP12 controls dendritic and myeloid cell migration to affect contact hypersensitivity. Journal of Immunology (Baltimore, Md. : 1950). 185: 4515-9. PMID 20861349 DOI: 10.4049/Jimmunol.1002227  0.663
2010 Uronis JM, Muehlbauer M, Keku TO, Herfarth HH, Rubinas TC, Arthur JC, Jobin C. 476 Intestinal Inflammation is Not Sufficient to Promote the Development of Colitis Associated Colorectal Cancer: Role of the Enteric Microbiota Gastroenterology. 138: S-66-S-67. DOI: 10.1016/S0016-5085(10)60302-2  0.358
2007 Arthur JC, Lich JD, Aziz RK, Kotb M, Ting JP. Heat shock protein 90 associates with monarch-1 and regulates its ability to promote degradation of NF-kappaB-inducing kinase. Journal of Immunology (Baltimore, Md. : 1950). 179: 6291-6. PMID 17947705 DOI: 10.4049/Jimmunol.179.9.6291  0.505
2007 Lich JD, Williams KL, Moore CB, Arthur JC, Davis BK, Taxman DJ, Ting JP. Monarch-1 suppresses non-canonical NF-kappaB activation and p52-dependent chemokine expression in monocytes. Journal of Immunology (Baltimore, Md. : 1950). 178: 1256-60. PMID 17237370 DOI: 10.4049/Jimmunol.178.3.1256  0.557
2006 Lich JD, Arthur JC, Ting JP. Cryopyrin: in from the cold. Immunity. 24: 241-3. PMID 16546091 DOI: 10.1016/J.Immuni.2006.03.004  0.526
2004 Sumida SM, McKay PF, Truitt DM, Kishko MG, Arthur JC, Seaman MS, Jackson SS, Gorgone DA, Lifton MA, Letvin NL, Barouch DH. Recruitment and expansion of dendritic cells in vivo potentiate the immunogenicity of plasmid DNA vaccines. The Journal of Clinical Investigation. 114: 1334-42. PMID 15520866 DOI: 10.1172/Jci22608  0.361
2004 Sumida SM, Truitt DM, Kishko MG, Arthur JC, Jackson SS, Gorgone DA, Lifton MA, Koudstaal W, Pau MG, Kostense S, Havenga MJ, Goudsmit J, Letvin NL, Barouch DH. Neutralizing antibodies and CD8+ T lymphocytes both contribute to immunity to adenovirus serotype 5 vaccine vectors. Journal of Virology. 78: 2666-73. PMID 14990686 DOI: 10.1128/Jvi.78.6.2666-2673.2004  0.321
Show low-probability matches.